JP, F., J, M., P, M., L, M., A, S., F, Z., . . . F, V. (2026). Impact of dapagliflozin, spironolactone and their combination on markers of kidney function and injury: An analysis from SOGALDI-PEF. European journal of heart failure. https://doi.org/10.1093/ejhf/xuag117
Chicago Style (17th ed.) CitationJP, Ferreira, et al. "Impact of Dapagliflozin, Spironolactone and Their Combination on Markers of Kidney Function and Injury: An Analysis from SOGALDI-PEF." European Journal of Heart Failure 2026. https://doi.org/10.1093/ejhf/xuag117.
MLA (9th ed.) CitationJP, Ferreira, et al. "Impact of Dapagliflozin, Spironolactone and Their Combination on Markers of Kidney Function and Injury: An Analysis from SOGALDI-PEF." European Journal of Heart Failure, 2026, https://doi.org/10.1093/ejhf/xuag117.